Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

4.41
Delayed Data
As of Dec 15
 -0.20 / -4.34%
Today’s Change
1.17
Today|||52-Week Range
6.55
+72.94%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sherman Michael A
President, Chief Executive & Financial Officer
Buy5/31/201744,285$2.10$93.0K+72.94%
Leamon Christopher P
Vice President-Research
Sale12/01/201718,194$5.03$91.5K-13.87%
Leamon Christopher P
Vice President-Research
Buy12/01/201726,178$3.06$80.1K-13.87%
Leamon Christopher P
Vice President-Research
Sale12/30/201623,244$2.55$59.3K+72.94%
Leamon Christopher P
Vice President-Research
Buy12/30/201626,178$2.10$55.0K+72.94%
Low Philip S
Chief Scientific Officer
Buy11/13/20175,600$4.84$27.1K-4.13%
Leamon Christopher P
Vice President-Research
Sale12/01/20175,037$5.05$25.4K-13.87%
Sherman Michael A
President, Chief Executive & Financial Officer
Sale2/04/20173,092$2.18$6.7K+102.29%
Low Philip S
Chief Scientific Officer
Sale2/04/20171,888$2.18$4.1K+102.29%
Leamon Christopher P
Vice President-Research
Sale2/04/20171,888$2.18$4.1K+102.29%
Page of 4